156
Participants
Start Date
December 4, 2024
Primary Completion Date
November 1, 2026
Study Completion Date
December 1, 2026
CRB-601 monoclonal antibody
CRB-601
Anti-PD-1 monoclonal antibody
Anti-PD(L)-1 used as per label
NOT_YET_RECRUITING
SCRI - Virginia Cancer Specialists, Fairfax
NOT_YET_RECRUITING
SCRI - Oncology and Hematology Associates of Southwest Virginia, Roanoke
NOT_YET_RECRUITING
Duke Cancer Center, Durham
NOT_YET_RECRUITING
Advent Health Oncology Hematology, Orlando
RECRUITING
SCRI- Lake Nona DDU, Orlando
NOT_YET_RECRUITING
University of Alabama at Birmingham, Birmingham
RECRUITING
SCRI - Nashville, Nashville
NOT_YET_RECRUITING
University Hospital of Cleveland (Case Western), Cleveland
NOT_YET_RECRUITING
SCRI - Minnesota Oncology Hematology, Maple Grove
NOT_YET_RECRUITING
University of Chicago, Chicago
RECRUITING
Nebraska Hematology Oncology, Lincoln
NOT_YET_RECRUITING
SCRI - OU Health Stephenson Cancer Center, Oklahoma City
NOT_YET_RECRUITING
SCRI- Texas Oncology, Tyler
RECRUITING
START - San Antonio, San Antonio
NOT_YET_RECRUITING
SCRI - Rocky Mountain Cancer Centers, Denver
NOT_YET_RECRUITING
SCRI - Arizona Oncology Associates, Tucson
NOT_YET_RECRUITING
The University of Arizona Cancer Center, Tucson
NOT_YET_RECRUITING
UC San Diego Health - Moores Cancer Center, La Jolla
NOT_YET_RECRUITING
University of California San Francisco, San Francisco
NOT_YET_RECRUITING
Cedars-Sinai Medical Center, Los Angeles
NOT_YET_RECRUITING
The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne
NOT_YET_RECRUITING
The Christie NHS Foundation Trust - Christie Hospital, Manchester
NOT_YET_RECRUITING
The Clatterbridge Cancer Center NHS Foundation Trust, Birkenhead
NOT_YET_RECRUITING
Edinburgh Cancer Research Centre, Edinburgh
NOT_YET_RECRUITING
Beatson West of Scotland Cancer Center, Glasgow
NOT_YET_RECRUITING
Guys and St Thomas NHS Foundation Trust, London
Lead Sponsor
Corbus Pharmaceuticals Inc.
INDUSTRY